Skip to main navigation
Skip to content
Search for:
Contact Us
Search for:
About Us
Locations
Leadership Team
Board of Directors
ABL Bio
Our Expertise
Technology
EpyQ® Production System
Platform Innovation
Gene Therapy Formulation
Scalable Manufacturing
Process Development
Aseptic Fill-Finish
Analytics & GMP QC Testing
Viral Vector Long‑Read NGS
Potency Assay Services
News & Insights
News
Articles
Blogs
Events
Resources
Posters
White Papers
Additional Resources
Careers
Contact Us
Scaling AAV Production: Transitioning From 250mL to 200L
1 May 2026
by
Ascend Advanced Therapies
Share this
